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ABSTRACT
Cardiac rehabilitation (CR) is reported as effective program to improve coronary risk 
factors and increase exercise tolerance in patients with coronary artery disease (CAD) 
after cardiac events. Normally, the CR program is performed in 3 phases i.e. acute (phase 
I), subacute (phase II), and chronic (phase III). In Indonesia, the most CR programs were 
conducted using  phase I and some phase II, whereas phase III CR program has not often 
been performed due to it is not covered by national health insurance. The aim of the study 
was to evaluate the effects of phase III comprehensive CR program on physical status 
and coronary risk factors among CAD patients. Seventy-four patients were stratified as 
the intervention group (n=37) and the control group (n=37). In the intervention group, 
patients participated in an hospital-based phase III CR program for 6 months, whereas 
in the control group, patients received a standard care. The CR program consists of 
warm-up, aerobic exercise, cool-down stretching, and health education session three 
days a week. Blood glucose level and lipid profile examinations were performed before 
and sixth month after the program implemented to assess patient’s metabolic status. 
Among 74 patients involved in this study, most patients were male (85.1%) with mean 
age 54.7±3.4 years old. Fifty-seven patients had post-procedural history (77% post-
PCI, 4% post-CABG), 8 patients (11%) were still active smokers, 31 patients (42%) had 
diabetes, and 60 patients (81%) had hypertension. Participation in the hospital-based 
phase III CR program was significantly correlated with lower low-density lipoprotein 
(LDL) level (p=0.003; r=0.41), triglyceride level (p=0.001; r=0.38), and fasting blood 
glucose level (p<0.001; r=0.46) during 6-month follow up. In conclusion, patients with 
CAD who undergo hospital-based phase III CR program have significantly better fasting 
glucose control, LDL, and triglyceride levels. These results may encourage other hospitals 
to perform the same program achieving better prognosis of CAD patients.
ABSTRAK
Rehabilitasi jantung (RJ) dilaporkan merupakan program yang efektif untuk menurunkan 
faktor risiko dan meningkatkan toleransi latihan fisik pada pasien dengan penyakit 
jantung koroner (PJK) setelah kejadian kardiovaskuler. Umumnya, program RJ dilakukan 
dalam 3 fase yaitu fase akut (fase I), subakut (fase II) dan kronik (fase III). Di Indonesia, 
sebagian besar program RJ dilakukan hanya sampai fase I, beberapa sampai fase II, 
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sedangkan program RJ fase III belum banyak dilakukan karena tidak dibiayai oleh Badan 
Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan). Tujuan penelitian ini adalah 
untuk mengevaluasi efek program RJ komprehensif fase III terhadap kondisi fisik dan 
factor risiko coroner pasien penderita PJK. Limapuluh empat penderita PJK dibagi ke dalam 
kelompok intervensi (n=37) dan kelompok kontrol (n=37). Pada kelompok intervensi, 
pasien menjalani program RJ fase III di rumah sakit selama 6 bulan, sedangkan kelompok 
kontrol pasien menjalani perawatan standar. Program RJ meliputi senam jantung sehat, 
senam aerobik, pendinginan dengan peregangan dan penyuluhan kesehatan 3 hari per 
minggu. Pemeriksaan kadar gula darah dan profil lipid dilakukan sebelum dan 6 bulan 
sesudah pelaksanaan program untuk menilai status metabolism pasien. Diantara 74 
pasien yang terlibat dalam penelitian, sebagian besar (85.1%) laki-laki dengan rerata 
umur 54,7 ± 3,4 tahun. Sebanyak 57 pasien memiliki riwayat pernah menjalani operasi 
jantung (post-PCI 77%; post-CABG 4%), 8 pasien (11%) masih aktif merokok, 31 pasien 
(42%) menderita diabetes dan 60 psien (81%) menderita hipertensi. Keikutsertaan dalam 
program RJ fase III di rumah sakit berhubungan nyata dengan kadar LDL (p=0,003; 
r=0,41), trigliserid (p=0,001; r=0,38) dan gula darah puasa (p<0,001; r=0,46) yang 
lebih rendah setelah 6 bulan mengikuti program.  Dapat disimpulkan, pasien PJK yang 
menjalani program RJ fase III di rumah sakit mempunyai kadar gula darah puasa, LDL 
dan trigliserid yang lebih baik secara nyata. Hasil ini dapat mendorong rumah sakit untu 
melaksanakan program yang sama dalam rangka memperbaiki prognosis pasien PJK.          
Keywords: cardiac rehabilitation - high density lipoprotein - low density lipoprotein – 
triglyceride - blood glucose
INTRODUCTION
Cardiovascular diseases (CVDs) are 
the leading cause of death globally. It is 
estimated 7.4 million deaths per year due to 
ischemic heart disease.1 Indonesian National 
Health Survey (RISKESDAS) in 2013 placed 
cardiac-cerebro-vascular disease as the top 
rank of cause of death in Indonesia.2 These 
catastrophic diseases are known as non-
communicable and preventable diseases. 
Establishing a preventive strategy, numerous 
studies were conducted in multicenter 
worldwide, in order to determine the efficacy 
of physical activity in reducing cardiovascular 
(CV) mortality. Anderson et al.3 demonstrated 
the importance of cardiac rehabilitation (CR) 
in coronary arterydisease (CAD) patients 
after cardiac events. This study revealed 
the significant benefits of CR to decrease 
total mortality, myocardial infarction, and 
revascularization. Moreover, CR could 
improve coronary risk factors, provide cost-
effectiveness as secondary CVD prevention, 
and increase quality of life (QoL) and exercise 
tolerance.3-5
In general, CR programs are performed in 
three main stages: acute stage (phase I), sub-
acute stage (phase II), and chronic stage (phase 
III).6-8 Phase I CR starts immediately from 
the first day of patient admission in hospital. 
Phase II CR exists in a multidisciplinary 
program requiring a series of knowledge and 
skills to bring together medical treatment, risk 
factor control, education, exercise training, 
and counseling for all people with CAD. 
Afterward, maintaining what have been done 
in phase II in community is the main part of 
phase III CR program.7,8 In Indonesia, most 
cardiac rehabilitation programs have been 
phase I and some phase II, whereas phase III 
CR has not often been performed since it was 
not covered by National Health Insurance 
yet.9 Therefore, limited data are available 
regarding the effects of phase III cardiac 
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rehabilitation on metabolic status, particularly 
in local population.
This study aimed to assess the beneficial 
effects of 6-month hospital-based phase III 
CR program on physical status and coronary 
risk factors among CAD patients.
MATERIALS AND METHODS
Subjects
During January-June 2016, we retro-
spectively enrolled 74 consecutive patients 
in cardiology outpatient clinic who were 
more than 40 years old. The all patients had 
been referred at least 6 months after a major 
coronary event, such as acute myocardial 
infarction, coronary artery bypass grafting, 
or percutaneous coronary intervention (PCI). 
Thirty-seven patients who consistently 
(>90% attendance) attending in a phase III 
CR program at Pupuk Kaltim Hospital were 
categorized as intervention group. Thirty-
seven other  patients who did not join in phase 
III CR program were categorized as control 
group. Patients with on going congestive heart 
failure, liver dysfunction (aspartate amino 
transferase ≥40 IU/L), renal dysfunction 
(creatinine ≥2.0 mg/dL), or systemic diseases 
(malignancy and collagen disease) were 
excluded.
Protocols 
Entire subjects were directed for blood 
sample work up in order to have base line 
of metabolic parameters, comprise of body 
mass index (BMI), blood pressure, lipid 
profile (low-density lipoprotein/LDL, high-
density lipoprotein/HDL, total cholesterol 
and triglycerides), blood glucose profile 
(fasting and 2 hours post prandial blood 
glucose levels) in 0 and 6 months observation. 
These laboratory parameters were determined 
in Pupuk Kaltim Hospital laboratories using 
direct measurement by homogenous assay of 
COBAS INTEGRA 400 plus analyzer.
In the intervention group, subjects 
participated in a hospital-based phase III CR 
program, while the control group received 
usual outpatient care, including monthly 
medical examination by the physician in 
charge. Phase III CR program consists of 
warm-up (senam jantung sehat) for 10 
minutes, aerobic exercise for the next 40 
minutes, cool-down stretching for last 10 
minutes, and health education session three 
days a week. Blood pressure and heart rate 
were monitored during the program and in 
outpatient clinic. Laboratory measurements 
were performed at the beginning and sixth 
month to assess patient’s metabolic status.
Except for the rehabilitation protocol, 
standard medical care was provided for both 
groups. Lipid-lowering drugs (simvastatin 
or atorvastatin 20 mg) that may affect lipid 
levels were given at stable doses for at least 
4 weeks before entry, and the doses of these 
medications were not altered during the study 
period). The Research Ethics Committee of 
Pupuk Kaltim Hospital approved the protocol. 
All subjects received full verbal and written 
explanations of the nature and purpose of 
the study, and each gave written informed 
consent.
Data analysis
The data analysis was conducted using 
SPPS version 22.0. All numeric outcomes 
were analyzed for Kolmogorov-Smirnov 
test, a test of normality. We used unpaired 
t-test (for normal distributed variables) or 
Mann-Whitney test (for abnormal distributed 
variables) to compare means between 
groups. Moreover, multivariate analysis was 
performed using multivariate analysis of 
variance test.
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RESULTS
Among 74 patients involved in this study, 
most patients were over 50 years old and male 
dominant (81% in CR group and 89% in non-
CR group, 85% of overall subjects). Mean 
of BMI in CR group was 26.9 ± 3.1 kg/m2, 
compared to 27.3 ± 3.4 kg/m2 in non-CR group. 
Non-CR group had slightly high percentage 
of hypertension, diabetes mellitus, smokers, 
and previous history of PCI compared to CR 
group (86.5 vs 75.6%; 43.2 vs 40.5%; 13.5 
vs 8.1% and 81.1 vs 72.9%). In contrast, the 
percentage of dyslipidemia, family history of 
CAD, previous coronary artery bypass graft 
(CABG) and non-intervention subjects in CR 
group were marginally greater than non-CR 
group (65 vs 62.1%; 24.3 vs 19%; 5.4 vs 2.7% 
and 21.7 vs 16.2%). There was no statistically 
difference between lipid drug consumed by the 
patients. Most patients received atorvastatin 
20 mg once daily instead of simvastatin. 
Left ventricular ejection fraction (LVEF) 
by echocardiography examination showed 
grossly equivalent in both arms and within 
normal limit (TABLE 1).
TABLE 1. Baseline characteristic between groups
Characteristic CR (n = 37)
non-CR 
(n = 37) p
Age (years old) 54.4 ± 3.6 55.1 ± 3.3 0.391
Male [n (%)] 30 (81.1) 33 (89.1) 0.327
BMI (kg/m2, mean ± SD) 26.9 ± 3.1 27.3 ± 3.4 0.299
Hypertension [n (%)] 28 (75.6) 32 (86.5) 0.374
Dyslipidemia [n (%)] 24 (64.9) 23 (62.1) 0.346
Diabetes Mellitus [n (%)] 15 (40.5) 16 (43.2) 0.814
Smokers [n (%)] 3 (8.1) 5 (13.5) 0.714
Family history of CAD [n (%)] 9 (24.3) 7 (18.9) 0.705
Previous PCI [n (%)] 27 (72.9) 30 (81.1) 0.678
Previous CABG [n (%)] 2 (5.4) 1 (2.7) 0.881
Non intervention [n (%)] 8 (21.7) 6 (16.2) 0.749
Statin therapy
•	 Simvastatin 20 mg [n (%)] 12 (32.4) 11 (19.7) 0.876
•	 Atorvastatin 20 mg [n (%)] 25 (67.6) 26 (70.3) 0.891
LVEF (mean ± SD %) 53.0 ± 12.1 55.1 ± 13.7 0.697
CR: cardiac rehabilitation (intervention group), non-CR:non-cardiac rehabilitation 
(control group), CAD: Coronary artery disease, PCI: percutaneous coronary intervention, 
CABG: coronary artery bypass graft, LVEF: left ventricle ejection fraction. The data were 
presented as a mean + SD values unless stated otherwise.
After 6 months observation in CR and 
non-CR group, several metabolic parameters 
via laboratory examination revealed some 
changes in terms of fasting blood levels, 2 
hours post prandial blood glucose level and 
lipid profile (LDL, HDL, total cholesterol and 
triglycerides levels) if compared 0 month of 
baseline data. In non-CR group, grossly the 
data showed worsening of metabolic status 
compared to baseline. In contrary, the trends 
on reduction of those metabolic parameters 
were observed in CR groups (TABLE 2). 
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TABLE 2. Blood glucose and lipid profile (mean ± SD mg/dL) pre- and post- CR program
Variable
CR (n = 37) non-CR (n = 37)
0-month 6-month 0-month 6-month
Fasting blood glucose 106.2 ± 17.1 100.1 ± 15.8 117.0 ± 32.7 119.7 ± 44.2
2 hr PP blood glucose 154.1 ± 36.7 148.8 ± 31.3 156.4 ± 51.3 154.9 ± 58.4
Total cholesterol 175.3 ± 39.0 170.8 ± 44.8 175.2 ± 48.5 170.4 ± 39.9
LDL-cholesterol 113.8 ± 28.8 107.1 ± 29.2 121.8 ± 37.1 124.9 ± 27.6
HDL-cholesterol 45.1 ± 9.4 43.7 ± 10.5 42.9 ± 13.7 41.8 ± 12.8
Triglyceride 130.1 ± 48.4 119.6 ± 40.7 153.9 ± 63.6 163.8 ± 77.9
CR: cardiac rehabilitation (intervention group); non-CR:non-cardiac rehabilitation (control group); 2hrPP: 
2-hour post prandial; LDL: low density lipoprotein; HDL: high density lipoprotein. 
Subsequently, coronary risk assessment in 
CR group compare to non-CR group exhibited 
statistically significant reduction in FBG level 
(p<0.001), LDL-C (p=0.003) and triglycerides 
(p=0.001). Pearson correlation test was done 
indicating a moderate correlation between 
phase III CR program and fasting blood 
glucose or LDL cholesterol level (r=0.46; 
0.41). Moreover, weak positive correlation 
between serum triglyceride and phase III CR 
program were observed (r =0.38) (TABLE 3). 
Multivariate analysis of variance showed that 
there was still a significant difference between 
CR and non CR group in terms of FBG, LDL, 
and triglyceride level when considering jointly 
over these 3 different variables (p<0.001; 
p=0.001;  p=0.002).
TABLE 3. Blood pressure, blood glucose level, lipid profile (mean ± SD) during follow-up
Variable CR (n = 37) non-CR (n = 37) p 
Systolic BP (mmHg) 128.1 ± 11.5 127.3 ± 9.6 0.977
Diastolic BP (mmHg) 83.5 ± 6.3 82.1 ± 6.2 0.536
Fasting blood glucose (mg/dL) 104.2 ± 13.9 119.0 ± 14.9 <0.001; r = 0.46
2hrPP blood glucose (mg/dL) 150.1 ± 32.7 161.4 ± 37.3 0.619
Total cholesterol (mg/dL) 173.3 ± 35.0 177.2 ± 36.2 0.681
LDL-cholesterol (mg/dL) 110.4 ± 22.8 121.84 ± 22.1 0.003; r = 0,41
HDL-cholesterol (mg/dL) 44.1 ± 8.4 42.9 ± 9.7 0.176
Triglyceride  (mg/dL) 124.1 ± 40.4 155.8 ± 39.1 0.001; r = 0.38
CR: cardiac rehabilitation (intervention group); non-CR: non-cardiac rehabilitation (control group); BP: 
blood pressure; 2hrPP: 2-hour post prandial; LDL: low density lipoprotein;  HDL: high density lipoprotein. 
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DISCUSSION
This research population were observed 
as homogenous in intervention and non-
intervention group. The results presented 
statistically significant reduction of fasting 
blood glucose (p<0.001), LDL cholesterol 
(p<0.003) and triglycerides (p=0.001) in 
phase III CR group than non-CR group. 
Since, one of the main pillars of CR is 
exercise training, mainly dynamic and aerobic 
exercise have been related with increased of 
cardiorespiratory fitness.10,11 Bauer et al.12 
have demonstrated exercise training improves 
glucose metabolism, insulin signalling, 
lipid profile, endothelial function, and blood 
pressure as well as exercise tolerance, in both 
diabetic and non-diabetic patients. However, 
in diabetic patients these parameters were 
remarkably improved. Hindman et al.13 
reported declining of FBG and blood lipid 
profile in diabetic patients who participated 
in a CR program after the onset of MI. 
Similarly, our study showed improved glucose 
metabolism and lipid metabolism, especially 
LDL-C and triglycerides with continued 
hospital-based phase III CR after cardiac 
events.
The basic mechanism of physical exercise 
in controlling blood glucose and lipid levels are 
consist of improvement of insulin sensitivity, 
by increases the activity of AMP-dependent 
protein kinase (AMPK), thereby stimulating 
the uptake and metabolism of glucose and 
lipids in skeletal muscles.14 These changes can 
be seen starting from acute phase of exercise 
(1-2 hours) to the chronic phase of exercise 
program. Abolishment of musclin expression 
and increment in expression of GLUT4 were 
also observed in physical activity to improve 
insulin resistance.15
Analysis of lipid profile in our study 
confirmed the previous investigations. A 
significant decrease in total cholesterol and 
triglycerides was also reported by other 
authors.5 It was found that low-intensity and 
moderate exercise induces an increase in HDL 
and decreases triglycerides in healthy subjects. 
However, reduction of total cholesterol is not 
always detectable.16 Similarly, we did not get 
a significant reduction of total cholesterol. 
However, a significant decline of LDL-C 
and triglyceride were observed. Other 
investigation was conducted, only triglyceride 
were significantly decreased after 12 and 24 
weeks of CR in CAD patients.17 J-CARP trial 
in Japan,18 firmly consistent with our study, 
it stated not only greater enhancement lipid 
prolife but decrement of BMI, fat mass and 
Apo-AI were perceived. Magkos  et al.19 
reported a prolonged moderate-intensity 
aerobic exercise augments the clearance rate 
of very low density lipoprotein-triglyceride 
(VLDL-TG) from plasma by enhancing the 
efficiency of VLDL-TG removal from the 
circulation, without affecting VLDL-TG 
secretion by the liver. This augmentation of 
clearance rate of VLDL-TG from plasma is the 
main reason why triglycerides significantly 
reduced in 6 months patients who undergoing 
phase III CR program.
Phase III CR program yielded LDL-C 
levels enhancements with statically significant 
and moderate positive correlation. Mean 
LDL-C reduction after 6 months CR program 
is 6.7 mg/dL. The previous study revealed 
a 1.7% reduction in major coronary events 
occurred with each 1% lowering of LDL-C 
in CAD patient subjects.20 Notwithstanding, 
based on ESC guideline of dyslipidemia21 risk 
stratification, our subjects are categorized as 
very high risk patients. The target of LDL-C 
in very high risk population is below 70 mg/
dL,21,22 which means the target of LDL-C 
levels in our study were not yet achieved. Yet, 
the average improvement of LDL-C levels in 
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our population reached 5% of reduction. Thus, 
we realized that the phase III CR program 
is the key component toward LDL-C target 
despite of optimal lipid-lowering medications. 
Moreover, in this study, we observed that 
there were no significant differences between 
groups in terms of statin therapy prior to the 
intervention.  
Stevens et al.23 established the effects of 
fitness were somewhat more consistent than 
the effects of fatness. Hence, the best way to 
reduce the risk of mortality, fit persons need 
to attain or maintain a normal body weight, 
and normal weight persons need to attain or 
maintain at least a moderate level of fitness. 
And, the finest approach to be fit is having 
moderate intensity aerobic exercise regularly, 
150 minutes/weeks.24 Particularly in patients 
after cardiac event, continuing cardiac 
rehabilitation program in community levels is 
the leading way to be fit.
CONCLUSION
This study proves that patients with CAD 
who underwent hospital-based phase III 
CR program has significantly better fasting 
glucose control, LDL, and triglyceride level 
during 6-month follow up. Although this study 
is the first study that attempt to explore the role 
of phase III CR program in post myocardial 
infarction patients in Indonesia, we still need a 
larger number of subjects that represent multi 
ethnicity of general population. Therefore, we 
strongly recommend further multicenter team 
works to carry out the importance of phase III 
CR program in metabolic improvement, so 
that phase III CR program can be delivered 
in many centers in Indonesia and covered by 
national insurance program. This will lead to 
better prognosis of future cardiac events and 
quality of life among CAD patients.
ACKNOWLEDGEMENTS
We thank our colleagues from National 
Cardiovascular Center Harapan Kita Jakarta 
and Pupuk Kaltim Hospital, Bontang, East 
Kalimantan who provided insight, financial 
support, and expertise that greatly assisted the 
research. 
REFERENCES
1.  World Health Organization. WHO fact sheet: 
global status report on non communicable 
disease 2014. WHO. 2014. [cited 2016 
October 14]; Available from: http://www.
who.int/mediacentre/factsheets/fs317/en
2. Riset Kesehatan Dasar (RISKESDAS). 
Jakarta: Badan Penelitiandan Pengembangan 
Kesehatan, Departemen Kesehatan - Republik 
Indonesia, 2007.
3.  Anderson L, Oldridge N, Thompson DR, 
Olddridge N, Zwisler AD, Rees K, et 
al. Exercise-based cardiac rehabilitation 
for coronary heart disease: Cochrane 
systematic review and meta-analysis. 
J Am Coll Cardiol 2016; 67(1):1-12. 
https://doi.org/10.1016/j.jacc.2015.10.044
4.  Lavie CJ, Arena R, Franklin BA. 
Cardiac rehabilitation and healthy life-
Style interventions: rectifying program 
deficiencies to improve patient outcomes. 
J Am Coll Cardiol 2016; 67(1):13-5. 
https://doi.org/10.1016/j.jacc.2015.09.103
5.  Taylor RS, Brown A, Ebrahim S, Jolliffe 
J, Noorni H, Rees K, et al. Exercise-based 
rehabilitation for patients with coronary 
heart disease: systematic review and 
meta-analysis of randomized controlled 
trials. Am J Med 2004; 116(10): 682–92. 
h t t p s : / / d o i . o r g / 1 0 . 1 0 1 6 / j . a m j m e d . 
2004.01.009
6.  Vanhees L, Martens M, Beloka S, Stevens A, 
Avram A, Gaita D. Cardiac Rehabilitation: 
Europe. In: Perk J, Mathes P, Gohlke H, 
87
Dwiputra B  et al., Hospital-based phase III cardiac rehabilitation program improves low density lipoprotein,
triglyceride, and fasting blood glucose levels in coronary artery disease patients
Monpère C, Hellemans I, McGee H, editors. 
Cardiovascular prevention and rehabilitation. 
London: Springer-Verlag, 2007: 30-3. 
https://doi.org/10.1007/978-1-84628-502-
8_5
7.  Brown RA. Rehabilitation of patients with 
cardiovasculardisease: report of a WHO 
expert committee. WHO Tech Rep Ser 1964; 
270:3-46.
8.  Piotrowicz R, Wolszakiewicz J. Cardiac 
rehabilitation following myocardial 
infarction. Cardiol J 2008; 15(5): 481-7.
9.  Radi B. Cardiac rehabilitation in Indonesia. 
Global Heart 2009; 4(supp1):s49.
10. Stavropoulos-Kalinoglou A, Metsios GS, 
van Zanten JJV, Nightingale P, Kitas GD, 
Koutedakis Y. Individualised aerobic and 
resistance exercise training improves cardio-
respiratory fitness and reduces cardiovascular 
risk in patients with rheumatoid arthritis. 
Ann Rheum Dis 2013; 72:1819–25. 
h t t p s : / / d o i . o r g / 1 0 . 1 1 3 6 /
annrheumdis-2012-202075
11.  Dalager T, Justesen JB, Murray M, Boyle E, 
Sjøgaard G. Implementing intelligent physical 
exercise training at the workplace: health 
effects among office workers-a randomized 
controlled trial. Eur J Appl Physiol 2016; 
116(7): 1433-42.
 https://doi.org/10.1007/s00421-016-3397-8
12.  Bauer TA, Reusch JE, Levi M, Regensteiner 
JG. Skeletal muscle deoxygenation after the 
onset of moderate exercise suggests slowed 
microvascular blood flow kinetics in type 2 
diabetes. Diabetes Care 2007; 30(11): 2880-5. 
https://doi.org/10.2337/dc07-0843
13.  Hindman L, Falko JM, La Londe M, Snow R, 
Caulin-Glaser T. Clinical profile and outcomes 
of diabetic and nondiabetic patients in cardiac 
rehabilitation. Am Heart J 2005; 150(5): 1046-51. 
https://doi.org/10.1016/j.ahj.2005.04.002
14. Musi N, Fujii N, Hirshman MF, Ekberg 
I, Fröberg S, Ljungqvist O, et al. AMP-
activated protein kinase (AMPK) is activated 
in muscle of subjects with type 2 diabetes 
during exercise. Diabetes 2001; 50(5): 921-7. 
https://doi.org/10.2337/diabetes.50.5.921
15. Yu J, Zheng J, Liu XF, Feng ZL, Zhang 
XP, Cao LL, et al. Exercise improved lipid 
metabolism and insulin sensitivity in rats fed a 
high-fat diet by regulating glucose transporter 
4 (GLUT4) and musclin expression. Braz 
J Med Biol Res 2016; 49(5):e5129. http://
dx.doi.org/10.1590/1414-431X20165129 
https://doi.org/10.1590/1414-431X20165129
16. Durstine JL, Grandjean PW, Davis 
PG, Ferguson MA, Alderson NL, Du 
Bose KD. Blood lipid and lipoprotein 
adaptations to exercise: aquantitative 
analysis. Sports Med 2001; 31:1033–62. 
h t t p s : / / d o i . o rg / 1 0 . 2 1 6 5 / 0 0 0 0 7 2 5 6 -
200131150-00002
17. Sandor B, Nagy A, Toth A, Rabai M, Mezey 
B, Csatho A, et al. Effects of moderate 
aerobic exercise training on hemorheological 
and laboratory parameters in ischemic heart 
disease patients. PLoS ONE 2014; 9:1-8. 
https://doi.org/10.1371/journal.pone.0110751
18. Seki E, Watanabe Y, Shimada K, Sunayama 
S, Onishi T, Kawakami K, et al. Effects of a 
phase III cardiac rehabilitation program on 
physical status and lipid profiles in elderly 
patients with coronary artery disease: 
Juntendo Cardiac Rehabilitation Program 
(J-CARP). Circulation J 2008; 72:1230–34. 
https://doi.org/10.1253/circj.72.1230
19. Magkos F, Wright DC, Patterson BW, 
Mohammed BS, Mittendorfer B. Lipid 
metabolism response to a single, prolonged 
bout of endurance exercise in healthy young 
men. Am J Physiol Endocrinol Metab 2006; 
290:E355-E362.
 https://doi.org/10.1152/ajpendo.00259.2005
20. Thanassoulis G, Williams K, Ye K, Brook 
R, Couture P, Lawler PR, et al. Relations 
of change in plasma levels of LDL-C, non-
J Med Sci, Volume 49, No. 2, 2017 April: 80-88
88
HDL-C and apoB with risk reduction from 
statin therapy: a meta-analysis of randomized 
trials. J Am Heart Assoc 2014 Apr 14; 3(2): 
e000759.
 https://doi.org/10.1161/JAHA.113.000759
21.  Reiner Z, Catapano AL, De Backer G, Graham 
I, Taskinen MR, Wiklund O, et al. The task 
force for the management of dyslipidaemias 
of the European Society of Cardiology 
(ESC) and the European Atherosclerosis 
Society (EAS). ESC/EAS Guidelines 
for the management of dyslipidaemias. 
Eur Heart J 2011; 32:1769-818. 
https://doi.org/10.1093/eurheartj/ehr158
22. National Cholesterol Education Program 
(NCEP) Expert Panel on Detection Evaluation 
and Treatment of High Blood Cholesterol 
in Adults (Adult Treatment Panel III). Third 
Report of the National Cholesterol Education 
Program (NCEP) Expert Panel on Detection, 
Evaluation, and Treatment of High Blood 
Cholesterol in Adults (Adult Treatment Panel 
III): Final Report. Circulation 2002; 106(25): 
3143-421.
23.  Stevens J, Cai J, Evenson KR, Thomas R. 
Fitness and fatness as predictors of mortality 
from all causes and from cardiovascular disease 
in men and women in the lipid research clinics 
study. Am J Epidemiol 2002; 156(9):832-41. 
https://doi.org/10.1093/aje/kwf114
24. Piepoli MF, Hoes AW, Agewall S, 
Albus C, Brotons C, Catapano AL, et al. 
European Guidelines on cardiovascular 
disease prevention in clinical practice. 
Eur Heart J 2016; 37(29):2315–81. 
https://doi.org/10.1093/eurheartj/ehw106
